That a very interesting point you raise. A colleague of mine is dealing with serious Melanoma and currently receiving Keytruda treatment. I had mentioned Bisantrene and suggested that he talk with his oncologist about possible compassionate use.
I was talking to him today about this and after I got of the phone I did start thinking about the in human efficacy data Race/Dr T are very likely to have as a result of compassionate use of Bisantrene but cannot make public.
Ann: Notification regarding unquoted securities - RAC, page-53
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.62 |
Change
0.010(0.62%) |
Mkt cap ! $279.4M | |||
| Open | High | Low | Value | Volume |
| $1.61 | $1.66 | $1.61 | $196.3K | 120.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1749 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.61 | 200 | 1 |
View Market Depth
| Last trade - 13.18pm 29/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |